Orthopedic Footwear Market Analysis

Product (Slippers, Sandals, Shoes)

The shoes segment is estimated to hold 45% share of the global orthopedic footwear market by the end of 2036. Orthopedic shoes are used to provide support to flat feet. In addition, there are numerous benefits of orthopedic shoes such as shock absorption, stability, and high ability to walk as well as distributing weight evenly, this segment is predicted to grow in the market during the forecasted period.

Indication (Diabetes & Edema, Arthritis, Flat Feet, Heel Pain)

The diabetes & edema segment in the orthopedic footwear market is set to garner the highest gain in the upcoming years with 47%. This segment is said to be increasing the market growth owing to the rising cases of diabetes worldwide as diabetes results in swollen feet. According to the International Diabetes Federation, around 700 million people are predicted to suffer from diabetes by 2045.  Moreover, an increase in the number of diabetic patients in developing countries anticipates the demand for orthopedic footwear and diabetic footwear across the globe. The bulk of the approximately 422 million individuals with diabetes globally reside in low- and middle-income nations, and diabetes is directly responsible for 1.5 million fatalities annually.

Our in-depth analysis of the global orthopedic footwear market includes the following segments: